Competitor radar
The companies you watch and what they do: grants, trials, conferences and papers as we find them. And the labs that publish with their products.
In Lacuna: Intelligence › competitors · Leads › competitor users
The platform
From a sentence in a paper to a reason to reach out.
Lacuna reads methods and discussion sections, grants, trials, patents and catalogues from your company’s point of view, and turns them into opportunities you can explain: who, what problem, why your solution, and why reach out.
Four questions
Every opportunity answers four questions. These tools answer them.
A name is not an opportunity. An opportunity says who, what problem they documented, why your product could address it and why they would want to hear from you, with the evidence attached.
50,815 researchers with deep profiles in 148 countries · 30,404 verified quotes from 14,860 researchers · a contact email for 14,135 of them
Who?
Which researcher or research group have we identified?
DirectoryFind expertsBeyond your setInstitutionsContact emails, verified or assumedWhat problem?
What concrete challenge has the researcher documented, and where is the evidence?
Reported limitationsSignals: product × problemPain points by marketWhy your solution?
Why do we judge that your product or technology can address the problem?
Prospecting strategyProductsCompetitor usersInstrumentsWhy reach out?
What is the concrete, scientifically relevant reason to start a conversation?
Grants, trials, tendersConferencesAlertsBriefings
What we collect
Your market, read from the literature.
The same reading that finds a researcher’s problem also maps the market around it: your competitors, your own brand, the products and consumables in use, and where the field is going. All of it is in the platform, for everyone on every plan.
Your brand in the literature
Papers and preprints that cite your product or its method. Independent labs, outside your own team, are the real signal.
268,856 papers read to the methods section
In Lacuna: Intelligence › product radar
Companies
The companies in the market, with the corporate group they belong to. Open one for its products, people and activity.
7,395 companies' catalogues
In Lacuna: Intelligence › companies
Products
The product catalogue: who makes each product, and which researchers name it in their methods.
7,622 products named in methods sections
In Lacuna: Intelligence › products
Consumables and catalogue numbers
Kits, reagents and consumables, down to the catalogue number when the paper gives one, next to the makers' own catalogue lines.
219,892 catalogue numbers · 476,524 catalogue lines
In Lacuna: Intelligence › products
Antibodies
Antibody targets in the literature, and the antibodies labs name in their methods, with supplier and catalogue number where they give them.
In Lacuna: Intelligence › market
Instruments
The readers, cytometers, sequencers and platforms researchers report using: the installed base you sell against, or build on.
484,021 instrument mentions
In Lacuna: Leads › directory and signals
Patents
Patents in the life-science classes (A61, C12, G01N, C07K, C07H, B01L), with applicant and date.
8,584 patents
In Lacuna: Intelligence › market
Trends
Publication momentum by MeSH topic in the global literature: which methods and fields are growing, and which are fading.
In Lacuna: Intelligence › trends
Conferences
Life-science conferences and symposia, where your field meets. Exhibitors and speakers matched to profiles, and your own attendee lists too.
586 conferences
In Lacuna: Intelligence › conferences
Grants, trials and tenders
Dated events on the researchers and companies you watch: new funding, trial registrations and public procurement.
6,132 grants · 5,471 trials · 8,926 tenders
In Lacuna: Today · Alerts
Distributors and CROs
Which distributors carry which brands, and the contract research organisations active in your field.
In Lacuna: Intelligence › market
Figures counted from the database on 2026-10-10, not rounded up for the website.
How it works
Read. Check. Fit. Reach out.
01 · Read
The part of the paper nobody sells from
Titles and abstracts say what a study found. The methods and discussion sections say what it was done with, and what went wrong. That is where the instrument, the antibody and the catalogue number live, and where a researcher writes that the CV was too high or the assay would not scale.
02 · Check
Every claim against its own source
Each problem is checked against the sentence it came from and dropped when it does not hold up; each product mention has to be grounded in the text before it is kept. That is why our verified count is smaller than our extracted count, and why we publish both.
03 · Fit
Reshaped around what you sell
Everyone gets the whole dataset. What changes is the lens: tell us your products and your competitors, and the matching, ranking, alerts and briefings reorder around your case.
04 · Reach out
Their problem, not your pitch
Every opportunity arrives with the quote it is based on, the paper behind it, and why we think your product fits. The first line of your message is about their work.
See it on your own market.
Bring one product. In a screen-share we show you researchers who have described the problem it solves, and the market around them. Prices are public: monthly or yearly, cancel any time.